Rhenman & Partners Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-360,000
| Closed | -$13.1M | – | 110 |
|
|
2016
Q4 | $13.1M | Buy |
360,000
+90,000
| +33% | +$3.26M | 2.5% | 7 |
|
|
2016
Q3 | $12.4M | Buy |
+270,000
| New | +$12.4M | 1.97% | 16 |
|
|
2015
Q3 | – | Sell |
-92,000
| Closed | -$5.44M | – | 96 |
|
|
2015
Q2 | $5.44M | Buy |
92,000
+42,000
| +84% | +$2.48M | 0.65% | 50 |
|
|
2015
Q1 | $3.12M | Buy |
+50,000
| New | +$3.12M | 0.53% | 65 |
|
|
2014
Q4 | – | Sell |
-59,000
| Closed | -$3.17M | – | 93 |
|
|
2014
Q3 | $3.17M | Buy |
59,000
+34,000
| +136% | +$1.83M | 0.93% | 38 |
|
|
2014
Q2 | $1.31M | Sell |
25,000
-82,922
| -77% | -$4.35M | 0.39% | 79 |
|
|
2014
Q1 | $5.7M | Buy |
107,922
+42,922
| +66% | +$2.27M | 1.71% | 13 |
|
|
2013
Q4 | $2.61M | Buy |
+65,000
| New | +$2.61M | 1.02% | 43 |
|